Molecular and Cellular Mechanisms of Rapid-Acting Antidepressants Ketamine and Scopolamine

E-ISSN： 1875-6190|15|1|11-20

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.15, Iss.1, 2016-12, pp. : 11-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rapid-Acting Antidepressants

Current Pharmaceutical Design, Vol. 24, Iss. 22, 2018-06 ,pp. : 2556-2563

Bentham Science Publishers

Access to resources Recommend Favorite

Nateglinide: a new rapid-acting insulinotropic agent

By Kumar Sudhesh Hanif Wasim

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 6, 2001-06 ,pp. : 1027-1031

Informa Healthcare

Access to resources Recommend Favorite

Insulin glulisine: a new rapid-acting insulin analogue for the treatment of diabetes

By Garg Satish K Ellis Samuel L Ulrich Heather

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 4, 2005-04 ,pp. : 643-651

Informa Healthcare

Access to resources Recommend Favorite

Insulin aspart: a novel rapid-acting human insulin analogue

By Gammeltoft S. Hansen B.F. Dideriksen L. Lindholm A. Schäffer L. Trüb T. Dayan A. Kurtzhals P.

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 9, 1999-09 ,pp. : 1431-1442

Informa Healthcare

Access to resources Recommend Favorite

Editorial (Thematic Selection: #39;Glutamatergic-based Rapid Acting Antidepressants: The Link to Synaptic Plasticity#39;)

Current Neuropharmacology, Vol. 15, Iss. 1, 2016-12 ,pp. : 2-2

Bentham Science Publishers

Access to resources Recommend Favorite